Evidence map›Paper›PMID 28180290›Full record

ArticleNucleic acids research2017

KDM2A integrates DNA and histone modification signals through a CXXC/PHD module and direct interaction with HP1.

Julie Borgel, Marek Tyl, Karin Schiller, Zsofia Pusztai, Christopher M Dooley, Wen Deng, Carol Wooding, Richard J White, Tobias Warnecke, Heinrich Leonhardt and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Julie BorgelMRC Clinical Sciences Centre (CSC), Du Cane Road, London, UK.
Marek TylMRC Clinical Sciences Centre (CSC), Du Cane Road, London, UK.
Karin SchillerMRC Clinical Sciences Centre (CSC), Du Cane Road, London, UK.
Zsofia PusztaiWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Christopher M DooleyWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Wen DengDepartment of Biology II, Center for Integrated Protein Science Munich, Ludwig Maximilians University (LMU Munich), Planegg-Martinsried, Germany.
Carol WoodingMRC Clinical Sciences Centre (CSC), Du Cane Road, London, UK.
Richard J WhiteWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Tobias WarneckeMRC Clinical Sciences Centre (CSC), Du Cane Road, London, UK.
Heinrich LeonhardtDepartment of Biology II, Center for Integrated Protein Science Munich, Ludwig Maximilians University (LMU Munich), Planegg-Martinsried, Germany.
Elisabeth M Busch-NentwichWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Till BartkeMRC Clinical Sciences Centre (CSC), Du Cane Road, London, UK.
MRC Clinical Trials Unit at UCL · GBWellcome Sanger Institute · GBCenter for Integrated Protein Science Munich · DE

Funding

European Research Council 309952Medical Research Council MC_UP_1102/7Wellcome Trust
6 · The paper itself

Abstract

Functional genomic elements are marked by characteristic DNA and histone modification signatures. How combinatorial chromatin modification states are recognized by epigenetic reader proteins and how this is linked to their biological function is largely unknown. Here we provide a detailed molecular analysis of chromatin recognition by the lysine demethylase KDM2A. Using biochemical approaches we identify a nucleosome interaction module within KDM2A consisting of a CXXC type zinc finger, a PHD domain and a newly identified Heterochromatin Protein 1 (HP1) interaction motif that mediates direct binding between KDM2A and HP1. This nucleosome interaction module enables KDM2A to decode nucleosomal H3K9me3 modification in addition to CpG methylation signals. The multivalent engagement with DNA and HP1 results in a nucleosome binding circuit in which KDM2A can be recruited to H3K9me3-modified chromatin through HP1, and HP1 can be recruited to unmodified chromatin by KDM2A. A KDM2A mutant deficient in HP1-binding is inactive in an in vivo overexpression assay in zebrafish embryos demonstrating that the HP1 interaction is essential for KDM2A function. Our results reveal a complex regulation of chromatin binding for both KDM2A and HP1 that is modulated by DNA- and H3K9-methylation, and suggest a direct role for KDM2A in chromatin silencing.

Indexed as

AnimalsAnimals, Genetically ModifiedCell LineChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneCpG IslandsCricetinaeDNA MethylationF-Box ProteinsHEK293 CellsHeLa CellsHistonesHumansJumonji Domain-Containing Histone DemethylasesModels, GeneticMutationChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneF-Box ProteinsHistonesJumonji Domain-Containing Histone DemethylasesKDM2A protein, humanNucleosomesRecombinant Fusion Proteins

Identifiers

PMID28180290
PMCPMC5388433
OpenAlexW2533189192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.